{
  "docId": "019de515-46e8-778b-9aa2-edc9d4857990",
  "docSlug": "9b80ae10198fa4f452f4044732defb94",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 17 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 17,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-46e8-778b-9aa2-edc9d4857990/7",
  "deckHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990",
  "deckJsonHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990.json",
  "deckAnchorHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.31,
        "w": 0.53,
        "x": 0.043,
        "y": 0.479
      },
      "kind": "chart",
      "text": "Projected sales of gene-modified cell therapies by 2026",
      "attrs": {
        "chart_type": "bar",
        "x_axis_label": "Year",
        "y_axis_label": "WW Product Sales: ($M)",
        "x_axis_values": [
          "2020",
          "2021",
          "2022",
          "2023",
          "2024",
          "2025",
          "2026"
        ],
        "y_axis_values": [
          0,
          5000,
          10000,
          15000,
          20000,
          25000
        ]
      },
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43dba7c6-1bca-4ae4-8ac5-f474c99c44bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.329,
        "w": 0.303,
        "x": 0.647,
        "y": 0.5
      },
      "kind": "list",
      "text": "2022 focus has been on innovation and complexity:\n\"Other\" cell types (such as dendritic cells, stem cells or myeloid cells, among others) grew 129% in 2022 compared to 2021\nDevelopment of allogeneic therapies has increased more sharply (33%) than autologous modalities (23%) in the past year\nRapid growth in cell targets: TAA, GPRC5D, CLEC12A, CD22, CD276, CLDN18 and KRAS experienced 100+% yr/yr growth in 2022",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91ea8cc8-3dfc-4847-ba9c-2225c8975cf1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.193,
        "x": 0.745,
        "y": 0.25
      },
      "kind": "metric",
      "text": "$12.6B",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "880ffb3d-7eb9-4731-851c-c802d8201d3d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.036,
        "w": 0.104,
        "x": 0.289,
        "y": 0.201
      },
      "kind": "metric",
      "text": "650+",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93284901-7200-4b85-8b5e-6bf8a7a774ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.036,
        "w": 0.14,
        "x": 0.086,
        "y": 0.201
      },
      "kind": "metric",
      "text": "1,800+",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee80a69e-8baa-4f1a-ae56-8907d9851c39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.036,
        "w": 0.026,
        "x": 0.45,
        "y": 0.201
      },
      "kind": "metric",
      "text": "6",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f06d3954-ab28-4c24-b523-8945dd110abc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.215,
        "x": 0.734,
        "y": 0.201
      },
      "kind": "paragraph",
      "text": "Total amount of 2022 global financings for cell and gene therapy companies",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77631e24-73ad-4b0c-99a0-e20700e50974",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.18,
        "x": 0.45,
        "y": 0.252
      },
      "kind": "paragraph",
      "text": "New cell and gene therapies approved in 2022",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8109ca70-c37f-492b-84c8-bfbe7770db38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.18,
        "x": 0.071,
        "y": 0.252
      },
      "kind": "paragraph",
      "text": "Genetically-modified cell therapies in development",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9c12086-2b21-4290-b6c7-c0fee9750e1b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.18,
        "x": 0.274,
        "y": 0.252
      },
      "kind": "paragraph",
      "text": "Genetically-modified cell therapies in preclinical development",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adbcaee4-ac18-4431-b65c-11c9a7a8656c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.132,
        "x": 0.304,
        "y": 0.843
      },
      "kind": "source-note",
      "text": "Source: Evaluate Pharma",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "111121b9-c094-4bba-b6a2-d1cff0e01a2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.132,
        "x": 0.101,
        "y": 0.301
      },
      "kind": "source-note",
      "text": "Source: Evaluate Pharma",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c3236ab-10d8-4069-b094-45e90e91aa0d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.215,
        "x": 0.734,
        "y": 0.301
      },
      "kind": "source-note",
      "text": "Source: Alliance for Regenerative Medicine",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e0d90fb-2088-4aca-829e-8b8feff7584a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.132,
        "x": 0.304,
        "y": 0.301
      },
      "kind": "source-note",
      "text": "Source: Evaluate Pharma",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b081b705-8c9b-453e-b53c-64afabff64e9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.354,
        "x": 0.596,
        "y": 0.863
      },
      "kind": "source-note",
      "text": "Source: Saez-Ibañez, Ana Rosa, et al. \"Landscape of Cancer Cell Therapies: Trends and Real-World Data.\" Nature News, June 2022.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cedbd548-1bd5-46df-85f4-2ce1f880171c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.159,
        "x": 0.82,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee5d352c-5ec5-4a12-9297-3af96acbbb82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.54,
        "x": 0.043,
        "y": 0.07
      },
      "kind": "title",
      "text": "Continued Investment in Cell and Gene Therapy",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef5b0cfe-31a5-4eba-92cd-efffa685aa96",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 7,
      "beatId": "edc78ce1-8eb2-44b9-80a0-f28527214b45",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Market sizing is discussed on page 7",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}